[ 4] In addition to helping people lose weight, there is a lot of emerging data that GLP-1 agonists may significantly reduce the risk of heart attacks and strokes in patients with a history of cardiovascular disease by as much as 20%
Doctors prescribe it to help patients lower blood sugar and reduce cardiovascular risk
It varies, but most people can expect to lose about 5% to 15% of their starting weight over six months to a year, depending on diet, activity level, and how consistently they take the medication
More interestingly, several semimetallic nanomaterials, such as selenium (Se)- and tellurium (Te)-based nanoparticles, can also decrease intracellular GSH levels
You can see the same doctor each time
The average reported loss is about 1.5% of body weight per week at therapeutic dose, though individual results depend on starting weight, adherence, and lifestyle factors